nach oben

Current Diabetes Reports

Erschienen in:

06.06.2024 | REVIEW

Review Article – Diabetes Technology in the Hospital: An Update

verfasst von: Margaretha M. Visser, Roman Vangoitsenhoven, Pieter Gillard, Chantal Mathieu

Erschienen in: Current Diabetes Reports | Ausgabe 8/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

There have been many developments in diabetes technology in recent years, with continuous glucose monitoring (CGM), insulin pump therapy (CSII) and automated insulin delivery (AID) becoming progressively accepted in outpatient diabetes care. However, the use of such advanced diabetes technology in the inpatient setting is still limited for several reasons, including logistical challenges and staff training needs. On the other hand, hospital settings with altered diet and stress-induced hyperglycemia often pose challenges to tight glycemic control using conventional treatment tools. Integrating smarter glucose monitoring and insulin delivery devices into the increasingly technical hospital environment could reduce diabetes-related morbidity and mortality. This narrative review describes the most recent literature on the use of diabetes technology in the hospital and suggests avenues for further research.

Recent Findings

Advanced diabetes technology has the potential to improve glycemic control in hospitalized people with and without diabetes, and could add particular value in certain conditions, such as nutrition therapy or perioperative management. Taken together, CGM allows for more accurate and patient-friendly follow-up and ad hoc titration of therapy. AID may also provide benefits, including improved glycemic control and reduced nursing workload.

Summary

Before advanced diabetes technology can be used on a large scale in the hospital, further research is needed on efficacy, accuracy and safety, while implementation factors such as cost and staff training must also be overcome.

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. https://doi.org/10.1056/NEJM199309303291401.CrossRef

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53. https://doi.org/10.1016/S0140-6736(98)07019-6.CrossRef

Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995;98:75–84. https://doi.org/10.1016/S0002-9343(99)80083-7.CrossRefPubMed

McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24. https://doi.org/10.1016/s0749-0704(05)70154-8.CrossRefPubMed

Fietsam R Jr, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg. 1991;57:551–7. https://doi.org/10.1097/00000539-199905000-00008.CrossRefPubMed

O’Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke. 1991;22:842–7. https://doi.org/10.1161/01.str.22.7.842.CrossRefPubMed

Carvalho RC, Nishi FA, Ribeiro TB, França GG, Aguiar PM. Association Between Intra-Hospital Uncontrolled Glycemia and Health Outcomes in Patients with Diabetes: A Systematic Review of Observational Studies. Curr Diabetes Rev. 2021;17:304–16. https://doi.org/10.2174/1573399816666200130093523.CrossRef

Smith L, Chakraborty D, Bhattacharya P, Sarmah D, Koch S, Dave KR. Exposure to hypoglycemia and risk of stroke. Ann N Y Acad Sci. 2018;1431:25–34. https://doi.org/10.1111/nyas.13872.CrossRefPubMedPubMedCentral

Nishioka Y, Okada S, Noda T, Myojin T, Kubo S, Ohtera S, et al. Absolute risk of acute coronary syndrome after severe hypoglycemia: A population-based 2-year cohort study using the National Database in Japan. J Diabetes Investig. 2020;11:426–34. https://doi.org/10.1111/jdi.13153.CrossRefPubMed

10.

Björk M, Melin EO, Frisk T, Thunander M. Admission glucose level was associated with increased short-term mortality and length-of-stay irrespective of diagnosis, treating medical specialty or concomitant laboratory values. Eur J Intern Med. 2020;75:71–8. https://doi.org/10.1016/j.ejim.2020.01.CrossRefPubMed

11.

American Diabetes Association. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46:S267-78. https://doi.org/10.2337/dc23-S016.CrossRef

12.

Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, et al. Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2022;107:2101–28. https://doi.org/10.1210/clinem/dgac278.CrossRefPubMedPubMedCentral

13.

American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119–31. https://doi.org/10.2337/dc09-9029.CrossRef

14.

American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553–91. https://doi.org/10.2337/diacare.27.2.553.CrossRef

15.

van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. https://doi.org/10.1056/NEJMoa011300.CrossRefPubMed

16.

Pease A, Lo C, Earnest A, Kiriakova V, Liew D, Zoungas S. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis. Diabetes Technol Ther. 2020;22:411–21. https://doi.org/10.1089/dia.2019.0417.CrossRefPubMed

17.

Kravarusic J, Aleppo G. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes. Endocrinol Metab Clin North Am. 2020;49:37–55. https://doi.org/10.1016/j.ecl.2019.10.006.CrossRefPubMed

18.

• Yeh T, Yeung M, Mendelsohn Curanaj FA. Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear. Curr Diab Rep. 2021;21:7. https://doi.org/10.1007/s11892-021-01375-7. (Previously published in Current Diabetes Reports, providing an overview of managing hospitalized patients on continuous glucose monitoring and insulin pump therapy)CrossRefPubMedPubMedCentral

19.

• Tian T, Aaron RE, Yeung AM, Huang J, Drincic A, Seley JJ, et al. Use of Continuous Glucose Monitors in the Hospital: The Diabetes Technology Society Hospital Meeting Report 2023. J Diabetes Sci Technol. 2023;17:1392–418. https://doi.org/10.1177/19322968231186575. (Very recent report on the progress of hospital use of continuous glucose monitoring (including automated insulin delivery), summarizing not only the potential benefits but also the unmet needs in the use of diabetes technology in the hospital)CrossRefPubMed

20.

Chen C, Zhao XL, Li ZH, Zhu ZG, Qian SH, Flewitt AJ. Current and Emerging Technology for Continuous Glucose Monitoring. Sensors (Basel). 2017;17:182. https://doi.org/10.3390/s17010182.CrossRefPubMed

21.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40:1631–40. https://doi.org/10.2337/dc17-1600.CrossRefPubMedPubMedCentral

22.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42:1593–603. https://doi.org/10.2337/dci19-0028.CrossRefPubMedPubMedCentral

23.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, et al. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes. J Endocr Soc. 2017;1:1445–60. https://doi.org/10.1210/js.2017-00388.CrossRefPubMedPubMedCentral

24.

Support | Product Guides & Tutorials | FreeStyle Libre Systems. Available from: https://www.freestyle.abbott/us-en/support.html. Accessed on Dec 1 2023.

25.

Dexcom | Product Guides. Available from: https://www.dexcom.com/en-us/guides. Accessed on Dec 1 2023.

26.

Medtronic | User guides & manuals. Available from: https://www.medtronicdiabetes.com/download-library. Accessed on Dec 1 2023.

27.

Glucomen Day CGM | Trainings and Guides. Available from: https://www.glucomenday.com/newplatform/glucomen-day-cgm/glucomen-day-cgm-training-and-guides/ Accessed on Dec 1 2023.

28.

Singh LG, Satyarengga M, Marcano I, Scott WH, Pinault LF, Feng Z, et al. Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial. Diabetes Care. 2020;43:2736–43. https://doi.org/10.2337/dc20-0840.CrossRefPubMedPubMedCentral

29.

Spanakis EK, Levitt DL, Siddiqui T, Singh LG, Pinault L, Sorkin J, et al. The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol. 2018;12:20–5. https://doi.org/10.1177/1932296817748964.CrossRefPubMed

30.

Fortmann AL, Spierling Bagsic SR, Talavera L, Garcia IM, Sandoval H, et al. Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting. Diabetes Care. 2020;43:2873–7. https://doi.org/10.2337/dc20-1016.CrossRefPubMedPubMedCentral

31.

Gómez AM, Umpierrez GE, Muñoz OM, Herrera F, Rubio C, Aschner P, et al. Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen. J Diabetes Sci Technol. 2015;10:325–9. https://doi.org/10.1177/1932296815602905.CrossRefPubMedPubMedCentral

32.

Galindo RJ, Migdal AL, Davis GM, Urrutia MA, Albury B, Zambrano C, et al. Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen. Diabetes Care. 2020;43:2730–5. https://doi.org/10.2337/dc19-2073.CrossRefPubMedPubMedCentral

33.

Davis GM, Galindo RJ, Migdal AL, Umpierrez GE. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia. Endocrinol Metab Clin North Am. 2020;49:79–93. https://doi.org/10.1016/j.ecl.2019.11.002.CrossRefPubMedPubMedCentral

34.

Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33:467–72. https://doi.org/10.2337/dc09-1352.CrossRefPubMed

35.

Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, et al. Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol. 2020;14:822–32. https://doi.org/10.1177/1932296820932903.CrossRefPubMedPubMedCentral

36.

Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, et al. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study. J Diabetes Sci Technol. 2020;14:1065–73. https://doi.org/10.1177/1932296820964264.CrossRefPubMedPubMedCentral

37.

Agarwal S, Mathew J, Davis GM, Shephardson A, Levine A, Louard R, et al. Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic. Diabetes Care. 2021;44:847–9. https://doi.org/10.2337/dc20-2219.CrossRefPubMed

38.

Chow KW, Kelly DJ, Rieff MC, Skala PA, Kravets I, Charitou MM, et al. Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU. J Diabetes Sci Technol. 2021;15:607–14. https://doi.org/10.1177/1932296820985263.CrossRefPubMedPubMedCentral

39.

Ushigome E, Yamazaki M, Hamaguchi M, Ito T, Matsubara S, Tsuchido Y, et al. Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes. Diabetes Technol Ther. 2021;23:78–80. https://doi.org/10.1089/dia.2020.0237.CrossRefPubMed

40.

Shehav-Zaltzman G, Segal G, Konvalina N, Tirosh A. Remote Glucose Monitoring of Hospitalized, Quarantined Patients With Diabetes and COVID-19. Diabetes Care. 2020;43:e75–6. https://doi.org/10.2337/dc20-0696.CrossRefPubMedPubMedCentral

41.

Reutrakul S, Genco M, Salinas H, Sargis RM, Paul C, Eisenberg Y, et al. Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience. Diabetes Care. 2020;43:e137–8. https://doi.org/10.2337/dc20-1503.CrossRefPubMedPubMedCentral

42.

Inoue S, Egi M, Kotani J, Morita K. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Crit Care. 2013;17:R48. https://doi.org/10.1186/cc12567.CrossRefPubMedPubMedCentral

43.

Burrin JM, Alberti KG. What is blood glucose: can it be measured? Diabet Med. 1990;7:199–206. https://doi.org/10.1111/j.1464-5491.1990.tb01370.x.CrossRefPubMed

44.

Roe JN. Biosensor development. Pharm Res. 1992;9:835–44. https://doi.org/10.1023/a:1015828311073.CrossRefPubMed

45.

Calhoun P, Johnson TK, Hughes J, Price D, Balo AK. Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System. J Diabetes Sci Technol. 2018;12:393–6. https://doi.org/10.1177/1932296818755797.CrossRefPubMedPubMedCentral

46.

Galindo RJ, Umpierrez GE, Rushakoff RJ, Basu A, Lohnes S, Nichols JH, et al. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. J Diabetes Sci Technol. 2020;14:1035–64. https://doi.org/10.1177/1932296820954163.CrossRefPubMedPubMedCentral

47.

Strasma PJ, Finfer S, Flower O, Hipszer B, Kosiborod M, Macken L, et al. Use of an Intravascular Fluorescent Continuous Glucose Sensor in ICU Patients. J Diabetes Sci Technol. 2015;9:762–70. https://doi.org/10.1177/1932296815585872.CrossRefPubMedPubMedCentral

48.

Clubbs Coldron B, Coates V, Khamis A, MacRury S. Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues. J Diabetes Sci Technol. 2023;17:467–73. https://doi.org/10.1177/19322968211053652.CrossRefPubMed

49.

Pasquel FJ, Umpierrez GE. Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic. J Diabetes Sci Technol. 2020;14:705–7. https://doi.org/10.1177/1932296820923045.CrossRefPubMedPubMedCentral

50.

Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr Pract. 2021;27:505–37. https://doi.org/10.1016/j.eprac.2021.04.008.CrossRefPubMed

51.

Avari P, Lumb A, Flanagan D, Rayman G, Misra S, Dhatariya K, et al. Continuous Glucose Monitoring Within Hospital: A Scoping Review and Summary of Guidelines From the Joint British Diabetes Societies for Inpatient Care. J Diabetes Sci Technol. 2023;17:611–24. https://doi.org/10.1177/19322968221137338.CrossRefPubMed

52.

Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021;9:174–88. https://doi.org/10.1016/S2213-8587(20)30381-8.CrossRefPubMedPubMedCentral

53.

Thompson B, Korytkowski M, Klonoff DC, Cook CB. Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. J Diabetes Sci Technol. 2018;12:880–9. https://doi.org/10.1177/1932296818769933.CrossRefPubMedPubMedCentral

54.

Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years’ experience with 253 cases. J Diabetes Sci Technol. 2012;6:995–1002. https://doi.org/10.1177/193229681200600502.CrossRefPubMedPubMedCentral

55.

Mibu K, Yatabe T, Hanazaki K. Blood glucose control using an artificial pancreas reduces the workload of ICU nurses. J Artif Organs. 2012;15:71–6. https://doi.org/10.1007/s10047-011-0611-7.CrossRefPubMed

56.

Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Tokumaru T, Iiyama T, et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care. 2014;37:1516–24. https://doi.org/10.2337/dc13-1771.CrossRefPubMed

57.

Namikawa T, Munekage M, Kitagawa H, Yatabe T, Maeda H, Tsukamoto Y, et al. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. J Artif Organs. 2017;20:84–90. https://doi.org/10.1007/s10047-016-0926-5.CrossRefPubMed

58.

Bally L, Thabit H, Hartnell S, Andereggen E, Ruan Y, Wilinska ME, et al. Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care. N Engl J Med. 2018;379:547–56. https://doi.org/10.1056/NEJMoa1805233.CrossRefPubMed

59.

Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2017;5:117–24. https://doi.org/10.1016/S2213-8587(16)30280-7.CrossRefPubMed

60.

Avari P, Lumb A, Flanagan D, Rayman G, Misra S, Choudhary P, et al. Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care. J Diabetes Sci Technol. 2023;17:625–34. https://doi.org/10.1177/19322968221137335.CrossRefPubMed

61.

Gómez Medina AM, Henao-Carrillo DC, Yepes C, Silva J, Gómez González JA, Cortes D, et al. Glycemic control metrics in a cohort of hospitalized patients with type 1 diabetes using hybrid closed-loop and advanced hybrid closed-loop systems. Diabetes Res Clin Pract. 2023;204:110897. https://doi.org/10.1016/j.diabres.2023.110897.CrossRefPubMed

62.

Boughton CK, Hartnell S, Hobday N, Lake A, Davenport K, Daly A, et al. Implementation of fully closed-loop insulin delivery for inpatients with diabetes: Real-world outcomes. Diabet Med. 2023;40:e15092. https://doi.org/10.1111/dme.15092.CrossRefPubMed

63.

Davis GM, Hughes MS, Brown SA, Sibayan J, Perez-Guzman MC, Stumpf M, et al. Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm. Feasibility Trial Diabetes Technol Ther. 2023;25:677–88. https://doi.org/10.1089/dia.2023.0304.CrossRefPubMed

64.

Umpierrez GE, Klonoff DC. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care. 2018;41:1579–89. https://doi.org/10.2337/dci18-0002.CrossRefPubMedPubMedCentral

65.

Thompson B, Leighton M, Korytkowski M, Cook CB. An Overview of Safety Issues on Use of Insulin Pumps and Continuous Glucose Monitoring Systems in the Hospital. Curr Diab Rep. 2018;18:81. https://doi.org/10.1007/s11892-018-1056-7.CrossRefPubMed

66.

DTS Continuous Glucose Monitoring in the Hospital Panel. Consensus Statement on Inpatient Use of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2017;11:1036–44. https://doi.org/10.1177/1932296817706151.CrossRef

67.

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46:S19-40. https://doi.org/10.2337/dc23-S002.CrossRef

68.

Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013;17:R159. https://doi.org/10.1186/cc12838.CrossRefPubMedPubMedCentral

69.

Van Herpe T, Mesotten D, Wouters PJ, Herbots J, Voets E, Buyens J, et al. LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial. Diabetes Care. 2013;36:188–94. https://doi.org/10.2337/dc12-0584.CrossRefPubMedPubMedCentral

70.

Laesser CI, Cumming P, Reber E, Stanga Z, Muka T, Bally L. Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and/or Enteral Nutrition: A Systematic Review. J Clin Med. 2019;8:935. https://doi.org/10.3390/jcm8070935.CrossRefPubMedPubMedCentral

71.

Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15:370–7. https://doi.org/10.4037/ajcc2006.15.4.370.CrossRefPubMed

72.

Cao L, Zhang D, Zhao Y, Zhou N, Zhang P. Efficacy and safety of different insulin infusion methods in the treatment of total parenteral nutrition-associated hyperglycemia: a systematic review and network meta-analysis. Front Nutr. 2023;10:1181359. https://doi.org/10.3389/fnut.2023.1181359.CrossRefPubMedPubMedCentral

73.

Boughton CK, Bally L, Martignoni F, Hartnell S, Herzig D, Vogt A, et al. Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7:368–77. https://doi.org/10.1016/S2213-8587(19)30061-0.CrossRefPubMedPubMedCentral

74.

Song IK, Lee JH, Kang JE, Park YH, Kim HS, Kim JT. Continuous glucose monitoring system in the operating room and intensive care unit: any difference according to measurement sites? J Clin Monit Comput. 2017;31:187–94. https://doi.org/10.1007/s10877-015-9804-6.CrossRefPubMed

75.

Tripyla A, Herzig D, Joachim D, Nakas CT, Amiet F, Andreou A, et al. Performance of a factory-calibrated, real-time continuous glucose monitoring system during elective abdominal surgery. Diabetes Obes Metab. 2020;22:1678–82. https://doi.org/10.1111/dom.14073.CrossRefPubMed

76.

Herzig D, Vettoretti M, Guensch DP, Melmer A, Schürch D, Roos J, et al. Performance of the Dexcom G6 Continuous Glucose Monitoring System During Cardiac Surgery Using Hypothermic Extracorporeal Circulation. Diabetes Care. 2023;46:864–7. https://doi.org/10.2337/dc22-2260.CrossRefPubMed

77.

Corney SM, Dukatz T, Rosenblatt S, Harrison B, Murray R, Sakharova A, et al. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions. J Diabetes Sci Technol. 2012;6:1003–15. https://doi.org/10.1177/193229681200600503.CrossRefPubMedPubMedCentral

78.

Sobel SI, Augustine M, Donihi AC, Reider J, Forte P, Korytkowski M. Safety and efficacy of a peri-operative protocol for patients with diabetes treated with continuous subcutaneous insulin infusion who are admitted for same-day surgery. Endocr Pract. 2015;21:1269–76. https://doi.org/10.4158/EP15727.OR.CrossRefPubMed

79.

Hanazaki K, Tanioka N, Munekage M, Uemura S, Maeda H. Closed-loop artificial endocrine pancreas from Japan. Artif Organs. 2021;45:958–67. https://doi.org/10.1111/aor.14008.CrossRefPubMed

80.

Vogt AP, Bally L. Perioperative glucose management: Current status and future directions. Best Pract Res Clin Anaesthesiol. 2020;34:213–24. https://doi.org/10.1016/j.bpa.2020.04.015.CrossRefPubMed

81.

Gunst J, Doig GS. The optimal blood glucose target in critically ill patients: more questions than answers. Intensive Care Med. 2017;43:110–2. https://doi.org/10.1007/s00134-016-4610-2.CrossRefPubMed

82.

• Spanakis EK, Cook CB, Kulasa K, Aloi JA, Bally L, Davis G, et al. A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials. J Diabetes Sci Technol. 2023;17:1527–52. https://doi.org/10.1177/19322968231191104. (Consensus statement for continuous glucose monitoring metrics for inpatient clinical trials, describing metrics for research on the use of continuous glucose monitoring in the hospital setting)CrossRefPubMed

Titel: Review Article – Diabetes Technology in the Hospital: An Update
verfasst von: Margaretha M. Visser
Roman Vangoitsenhoven
Pieter Gillard
Chantal Mathieu
Publikationsdatum: 06.06.2024
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 8/2024
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-024-01545-3

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Magendarminfekte: Dos and Don'ts bei Kleinkindern

18.02.2025
Akute Gastroenteritis
Podcast

Die Leitlinie zur akuten infektiösen Gastroenteritis wurde 2024 umfassend überarbeitet. Cola und Saft zur oralen Hydratation und einige Antidiarrhoika sollten vermieden werden. Von einem standardmäßigen Erregerpanel wird abgeraten. Die Hintergründe zu diesen und weiteren Empfehlungen erläutert Leitlinienkoordinator Prof. Carsten Posovszky.

Körperlich fitte Krebskranke leben länger

18.02.2025
Onkologische Erkrankungen in der Hausarztpraxis
Nachrichten

Krebspatienten, auch und vor allem solche in fortgeschrittenen Stadien, profitieren offenbar von guter körperlicher Verfassung. Hohe Muskelkraft und kardiorespiratorische Fitness sind laut Ergebnissen einer Metaanalyse mit geringerer Mortalität assoziiert.

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

17.02.2025
Ischämischer Schlaganfall
Nachrichten

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

HCL-Systeme bei Typ-1-Diabetes: Blutzuckerkontrolle besser, Risiko für Ketoazidose aber höher

Eine bessere Blutzuckerkontrolle und weniger Fälle von hypoglykämischem Koma, dafür mehr diabetische Ketoazidosen. Dieses HCL-Insulin-Therapie-Profil zeigte sich in einem Vergleich von Hybrid-Closed-Loop(HCL)- und Open-Loop-Systemen bei Typ-I-Diabetes im DPV-Register.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "(Cluster-)Kopfschmerzen und Migräne"

Springer Medizin

Review Article – Diabetes Technology in the Hospital: An Update